Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ann-Kathrin Frenz, Christiane Ahlers, Vita Beckert, Christoph Gerlinger & Tim Friede. (2021) Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems. The European Journal of Contraception & Reproductive Health Care 26:1, pages 48-57.
Read now
Read now
Thomas Faustmann, John Crocker, Carsten Moeller, Yvonne Engler, Cecilia Caetano & Kai J. Buhling. (2019) How do women and health care professionals view hormonal long-acting reversible contraception? Results from an international survey. The European Journal of Contraception & Reproductive Health Care 24:6, pages 422-429.
Read now
Read now
David Serfaty, Jean-Paul Bénézech, Sergine Heckel & Pia De Reilhac. (2019) Consensus of best practice in intrauterine contraception in France. The European Journal of Contraception & Reproductive Health Care 24:4, pages 305-313.
Read now
Read now
Norman D. Goldstuck. (2017) Clarification of the role of the Jaydess(Skyla) LNG- IUS 13.5mg and Kyleena LNG-IUS 19.5mg as intrauterine contraceptive systems. Expert Review of Medical Devices 14:8, pages 593-599.
Read now
Read now
Articles from other publishers (7)
Marie Linder, Juliane Schoendorf, Federica Pisa, Renate Schulze-Rath & Carolyn E. Cesta. (2023) Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014–2016. Contraception, pages 110309.
Crossref
Crossref
. (2023) FSRH Guideline (March 2023) Intrauterine contraception. BMJ Sexual & Reproductive Health 49:Suppl 1, pages 1-142.
Crossref
Crossref
Karin Elgemark, Sofie Graner, Julia McTaggart, Jennie Ramirez Löfström, Daniela Sörensen, Niklas Envall & Helena Kopp Kallner. (2022) The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy. Obstetrics & Gynecology 140:2, pages 227-233.
Crossref
Crossref
Milena Lewandowska, Richard De Abreu Lourenco, Marion Haas, Cathy J. Watson, Kirsten I. Black, Angela Taft, Jayne Lucke, Kevin McGeechan, Kathleen McNamee, Jeffrey F. Peipert & Danielle Mazza. (2021) Cost-effectiveness of a complex intervention in general practice to increase uptake of long-acting reversible contraceptives in Australia. Australian Health Review 45:6, pages 728-734.
Crossref
Crossref
Renata D.M.S. Alves, Maiara M. Rabelo, Venandra R. Andrade, Renata C.S. Cabral, Joely W. Merriman & Milena B. Brito. (2019) The influence of the levonorgestrel‐releasing intrauterine system position on bleeding patterns in reproductive age women. International Journal of Gynecology & Obstetrics 147:3, pages 326-331.
Crossref
Crossref
Sofie Graner, Julia Mc Taggart, Fanny Nordström, Emma Melander, Johan Widenberg & Helena Kopp Kallner. (2019) Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy. Acta Obstetricia et Gynecologica Scandinavica 98:7, pages 937-943.
Crossref
Crossref
Kristina Gemzell-Danielsson, Dan Apter, Eeva Lukkari-Lax, Katrin Roth & Marco Serrani. (2017) Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter ® in a majority nulliparous population. Contraception 96:6, pages 426-431.
Crossref
Crossref